I don't believe the revenue is going to get capped. The potential for up selling future products and targeted selling is massive. Also, the untapped potential when this goes international will see revenue from all angles.
I'm seeing that the GP Link is already punching on and successful. I would doubt that they would be launching it at the Royal Australian College of General Practitioners conference if this wasn't pumping.
If pharmacy uptake continues to grow at this rate, the barriers to entry for any competitor will be high. Medadvisor are monopolising this market. Solid medium to long term hold here.
I don't believe the revenue is going to get capped. The...
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MDR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
30.0¢ |
Change
0.010(3.45%) |
Mkt cap ! $215.0M | |||
| Open | High | Low | Value | Volume |
| 29.0¢ | 30.0¢ | 27.5¢ | $254.8K | 889.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 39326 | 30.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.5¢ | 2917 | 1 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| MDR (ASX) Chart |
